Human Genome Epidemiology Literature Finder
|
Records 1 - 16 (of 16 Records) |
| Query Trace: Li-Fraumeni Syndrome and MDM2[original query] |
|---|
| Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome. Journal of medical genetics 2006 Jun 43 (6): 531-3. Bougeard G, Baert-Desurmont S, Tournier I, Vasseur S, Martin C, Brugieres L, Chompret A, Bressac-de Paillerets B, Stoppa-Lyonnet D, Bonaiti-Pellie C, Frebourg |
| p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome. Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Oct 11 (19 Pt 1): 6840-4. Sotamaa Kaisa, Liyanarachchi Sandya, Mecklin Jukka-Pekka, Järvinen Heikki, Aaltonen Lauri A, Peltomäki Päivi, de la Chapelle Albe |
| MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Sep 24 (27): 4434-40. Ohmiya Naoki, Taguchi Ayumu, Mabuchi Nobuyuki, Itoh Akihiro, Hirooka Yoshiki, Niwa Yasumasa, Goto Hide |
| Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. Journal of the National Cancer Institute 2006 Feb 98 (4): 285-8. Menin Chiara, Scaini Maria Chiara, De Salvo Gian Luca, Biscuola Martina, Quaggio Monica, Esposito Giovanni, Belluco Claudio, Montagna Marco, Agata Simona, D'Andrea Emma, Nitti Donato, Amadori Alberto, Bertorelle Rober |
| MDM2 SNP309 T>G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients. International journal of cancer. Journal international du cancer 2007 Feb 120 (3): 563-5. Talseth Bente A, Meldrum Cliff, Suchy Janina, Kurzawski Grzegroz, Lubinski Jan, Scott Rodney |
| Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas. Brain pathology (Zurich, Switzerland) 2009 Apr 19 (2): 188-94. Zawlik Izabela, Kita Daisuke, Vaccarella Salvatore, Mittelbronn Michel, Franceschi Silvia, Ohgaki Hiro |
| Association of the germline TP53 R337H mutation with breast cancer in southern Brazil. BMC cancer 2008 8 (1): 357. Assumpção Juliana G, Seidinger Ana Luíza, Mastellaro Maria José, Ribeiro Raul C, Zambetti Gerard P, Ganti Ramapriya, Srivastava Kumar, Shurtleff Sheila, Pei Deqing, Zeferino Luiz Carlos, Dufloth Rozany M, Brandalise Silvia Regina, Yunes José Andr |
| TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis. Journal of medical genetics 2009 Jun . Marcel V, Palmero EI, Falagan-Lotsch P, Martel-Planche G, Ashton-Prolla P, Olivier M, Brentani RR, Hainaut P, Achatz MI |
| TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset. Familial cancer 2009 8 (4): 383-90. Pinto Carla, Veiga Isabel, Pinheiro Manuela, Peixoto Ana, Pinto Armando, Lopes José M, Reis Rui M, Oliveira Carla, Baptista Manuela, Roque Lúcia, Regateiro Fernando, Cirnes Luís, Hofstra Robert M W, Seruca Raquel, Castedo Sérgio, Teixeira Manuel |
| MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children's Oncology Group. Pediatric blood & cancer 2010 Aug 55 (2): 248-53. Phillips Christine L, Gerbing Robert, Alonzo Todd, Perentesis John P, Harley Isaac T W, Meshinchi Soheil, Bhatla Deepika, Radloff Gretchen, Davies Stella |
| TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Apr 28 (12): 1995-2001. Tabori Uri, Shlien Adam, Baskin Berivan, Levitt Sarah, Ray Peter, Alon Noa, Hawkins Cynthia, Bouffet Eric, Pienkowska Malgorzata, Lafay-Cousin Lucie, Gozali Alexa, Zhukova Nataliya, Shane Lisa, Gonzalez Ignacio, Finlay Jonathan, Malkin Dav |
| p53 Arg72Pro and MDM2 309 SNPs in hereditary retinoblastoma. Journal of human genetics 2011 Sep 56 (9): 685-6. Epistolato Maria Carmela, Disciglio Vittoria, Livide Gabriella, Berchialla Paola, Mencarelli Maria Antonietta, Marozza Annabella, Amenduni Mariangela, Hadjistilianou Theodora, De Francesco Sonia, Acquaviva Antonio, Toti Paolo, Cetta Francesco, Ariani Francesca, De Marchi Mario, Renieri Alessandra, Giachino Danie |
| Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome. Human genetics 2011 Jun 129 (6): 663-73. Wu Chih-Chieh, Krahe Ralf, Lozano Guillermina, Zhang Baili, Wilson Charmaine D, Jo Eun-Ji, Amos Christopher I, Shete Sanjay, Strong Louise |
| The MDM2 285G-309G haplotype is associated with an earlier age of tumour onset in patients with Li-Fraumeni syndrome. Familial cancer 2014 Mar 13 (1): 127-30. Renaux-Petel Mariette, Sesboüé Richard, Baert-Desurmont Stéphanie, Vasseur Stéphanie, Fourneaux Steeve, Bessenay Emilie, Frébourg Thierry, Bougeard Gaël |
| Evaluation of TP53 Pro72Arg and MDM2 SNP285-SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations. Familial cancer 2016 Mar . Ponti Francesca, Corsini Serena, Gnoli Maria, Pedrini Elena, Mordenti Marina, Sangiorgi Lu |
| Sex-Specific Associations of MDM2 and MDM4 Variants with Risk of Multiple Primary Melanomas and Melanoma Survival in Non-Hispanic Whites. Cancers 2023 6 15 (10): . Sarah V Ward, Isidora Autuori, Li Luo, Emily LaPilla, Sarah Yoo, Ajay Sharma, Klaus J Busam, David W Olilla, Terence Dwyer, Hoda Anton-Culver, Roberto Zanetti, Lidia Sacchetto, Anne E Cust, Richard P Gallagher, Peter A Kanetsky, Stefano Rosso, Colin B Begg, Marianne Berwick, Nancy E Thomas, Irene Orlow, |
- Page last reviewed:Feb 1, 2024
- Content source: